Stocks and Investing Stocks and Investing
Mon, September 16, 2024

Silvan Tuerkcan Reiterated (ACRV) at Buy and Held Target at $17 on, Sep 16th, 2024


Published on 2024-10-28 14:16:18 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $17 on, Sep 16th, 2024.

Silvan, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources